NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Buyout or partnership makes the most sense in terms of their posture, but then our share price doesn’t support buyout at this time. So partnership or some sort of spin off with DCVAX-L as the quarterback remains the most viable option. It really doesn't matter if the partner is Merck, Pfizer, Astrazeneca or Regeneron. The important thing is we need a credible and experienced pharma team to back NWBO right away as soon as UK approval is announced. If they dangle any more carrot like Flaskworks, it will become clear there is really no interest in our platform from big or mid size pharma.